APVO logo

APVO
Aptevo Therapeutics Inc

11,427
Mkt Cap
$6.28M
Volume
26,645.00
52W High
$235.98
52W Low
$3.80
PE Ratio
-0.02
APVO Fundamentals
Price
$4.95
Prev Close
$5.04
Open
$5.10
50D MA
$4.73
Beta
1.19
Avg. Volume
22,811.46
EPS (Annual)
-$87.27
P/B
0.51
Rev/Employee
$0.00
$14.01
Loading...
Loading...

About

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36

Frequently Asked Questions

What is Market Cap of Aptevo Therapeutics Inc?
What is the 52-week high for Aptevo Therapeutics Inc?
What is the 52-week low for Aptevo Therapeutics Inc?
What is Aptevo Therapeutics Inc stock price today?
What was Aptevo Therapeutics Inc stock price yesterday?
What is the PE ratio of Aptevo Therapeutics Inc?
What is the Price-to-Book ratio of Aptevo Therapeutics Inc?
What is the 50-day moving average of Aptevo Therapeutics Inc?
How many employees does Aptevo Therapeutics Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available